Global Downstream Processing Market Overview and Forecast to 2031 – Market Analysis and Market Share

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global Downstream Processing Market Overview and Forecast to 2031 – Market Analysis and Market Share

  • Healthcare
  • Upcoming Reports
  • Sep 2024
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Global Downstream Processing Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2024 –2031
Diagramm Marktgröße (Basisjahr)
USD 29.40 Billion
Diagramm Marktgröße (Prognosejahr)
USD 69.23 Billion
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

The Global Downstream Processing Market size in 2023 is USD 29.4 billion. The market share is growing at a CAGR of 11.3% and reach USD 69.23 billion by 2031.

Downstream Processing Market–

 

Global Downstream Processing Market - Industry Overview

The global downstream processing market is a crucial segment of the biopharmaceutical industry, focusing on the purification, isolation, and recovery of biopharmaceutical products from fermentation or cell culture processes. Downstream processing market encompasses several key stages, including cell harvesting to remove cells and debris, cell lysis to release intracellular products, and purification through advanced chromatography techniques such as affinity, ion exchange, and size exclusion chromatography. Innovations in downstream processing technologies, such as improved chromatography resins, single-use systems, and automation, are enhancing efficiency, yield, and cost-effectiveness, thus fueling the global downstream processing market growth.

Data Bridge Market Research Market Report provides details of new recent developments, market share, market trends on the basis of its segmentations and regional analysis, the impact of market players, analyses of opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research’s team of expert analysts. Our team will help you make informed market decisions to achieve business growth.

Global Downstream Processing Market Size

Global Downstream Processing Report Metric Details

 

Report Metric

Details

Forecast Period

2024-2031

Base Year

2023

Historic Year

2022 (Customizable 2016-2021)

Measuring Unit

USD Billion

Data Pointers

Market value, growth rate, market segments, geographical coverage, market players, and market scenario, in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, require complex, and precise downstream processing to achieve high levels of purity, efficacy, and safety. As the healthcare industry increasingly relies on these advanced therapies to treat a range of conditions, from cancer to autoimmune disorders, the need for effective purification and recovery processes has surged. As a result, Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Downstream Processing Market is increasing at a 11.3% CAGR of %. Our detailed analysis forecasts that the market is valued at USD 29.4 billion in 2023 and is expected to grow upto USD 69.23 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.

Global Downstream Processing Market Dynamics

Global Downstream Processing Market Growth Drivers

Automation and Process Integration

The integration of automation technologies, such as robotic systems and automated process controls improve downstream processing consistency, scalability, and dependability dramatically. Automated systems, such as the Ambr® 250 high-throughput bioreactor system, allow for the simultaneous culture of up to 24 bioreactors, speeding up development and manufacturing cycles. This improving efficiency, reducing operational costs, and supporting scalable production drives global downstream processing market growth.

Increasing Investment in Biopharmaceutical Manufacturing

Significant investment in biopharmaceutical production facilities, particularly in emerging areas such as Asia-Pacific, is driving up demand for downstream processing equipment and technology. For instance, Samsung Biologics and WuXi Biologics have made significant investments in developing their biomanufacturing capabilities, which has fueled the global downstream processing market growth.

Global Downstream Processing Market Growth Opportunities

Growing need for improved purification efficiency

Advances in chromatography and filtration technologies, such as high-resolution chromatography resins and advanced membrane filtration systems, significantly boost the efficiency and precision of biopharmaceutical purification. Such improvements lead to higher product yields and shorter processing times, driving growth in the global downstream processing market.

Rise in use of single-use systems

The use of single-use systems in downstream processing reduces the risk of cross-contamination, simplifies cleaning, and lowers operational expenses. By streamlining workflows and enhancing flexibility in biomanufacturing, single-use technologies are driving significant growth in the global downstream processing market.

Global Downstream Processing Market Growth Challenges

Environmental Concerns of Single-Use Technologies

Single-use technologies, while advantageous for reducing contamination risks and cutting operational costs, pose considerable environmental challenges due to the plastic waste they generate. The use of single-use bioreactors and disposable filters in the biopharmaceutical industry contributes to significant amounts of plastic waste. This issue is particularly severe in regions with stringent environmental regulations, such as California, where strict waste management and reduction practices are enforced. Companies operating in these areas face mounting pressure to adopt sustainable practices, such as investing in recyclable materials and enhancing waste disposal methods. These environmental concerns are a significant challenge for the global downstream processing market growth.

Global Downstream Processing Market Restraints

Regulations impeding market development

Regulatory compliance in downstream processing is challenging due to the rigorous standards imposed by agencies. For instance, in India, the Central Drugs Standard Control Organization (CDSCO) enforces stringent guidelines for downstream processing, particularly for biopharmaceuticals. These guidelines emphasize comprehensive process validation and the implementation of quality by design (QbD) principles to ensure consistent product quality throughout the manufacturing process. Such stringent requirements can create significant barriers and increase the complexity and cost of bringing new products to market, acting as a restraint on the global downstream processing market growth.

Global Downstream Processing Market Scope and Trends

Global Downstream Processing Market Segmentations Overview

Market

Sub-Segments

Technique

Purification(Cell separation, Filtration, Product recovery), Solid-Liquid Separation(filtration and centrifugation), Clarification & Concentration

Product

Chromatography Columns and Resins, Filters, Membrane Adsorbers, Single-Use Products, Other Products

End User

Biopharmaceutical Manufacturers, Contract Manufacturing Organizations

Application

Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Other Applications

  • Innovations in chromatography resins, such as those providing higher resolution and greater binding capacities, have improved the purification of complex biopharmaceuticals. For instance, new resins designed for Protein A affinity chromatography such as Thermo Scientific MabCaptureC enhance the purity of monoclonal antibodies by increasing their binding specificity and reducing impurities.
  • Depth filters and tangential flow filtration (TFF) systems have been upgraded with advanced materials and designs, boosting throughput and minimizing fouling to enhance separation efficiency in filtration technologies.
  • Ambr 250 high-throughput bioreactor, enable real-time monitoring and adjustment of concentration levels, which improves process control and reduces processing times.
  • Single-use filtration and concentration systems are gaining popularity due to their ease of use and reduced risk of cross-contamination. These systems, including single-use membrane filters and concentrators, simplify the process by eliminating the need for extensive cleaning and validation.

Global Downstream Processing Market Regional Analysis – Market Trends

Global Downstream Processing Market Regional Overview

 

Region

Countries

Europe

Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe

APAC

China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific

North America

U.S., Canada, and Mexico

MEA

Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East, and Africa

South America

Brazil, Argentina, and Rest of South America

Key Insights

  • The United States dominates the worldwide downstream processing market due to its mature biopharmaceutical industry and significant investment in innovative technology. For instance, large biopharmaceutical companies and contract manufacturing organizations (CMOs) like as Thermo Fisher Scientific and Lonza have significant downstream processing facilities, which drive market growth through innovation and technological advancements.
  • Asia-Pacific region is experiencing rapid growth driven by increasing biopharmaceutical manufacturing capabilities in countries like China and India. For instance, WuXi AppTec, a prominent Chinese biopharmaceutical company, is expanding its downstream processing capacity to support the rising demand for biologics and biosimilars.
  • The European market is expanding with advanced bioprocessing facilities in countries like Germany and Switzerland. The region’s adherence to stringent regulatory standards, such as those set by the European Medicines Agency (EMA), ensures high-quality production. Companies like Sartorius and Eppendorf are key contributors to the market, offering sophisticated downstream processing technologies and solutions.

Leading Players in the Global Downstream Processing Market

  • 3M
  • Repligen Corporation
  • Boehringer Ingelheim International GmbH
  • Eppendorf AG
  • Lonza
  • Corning Incorporated
  • Asahi Kasei Corporation
  • Dover Corporation
  • Thermo Fisher Scientific Inc.
  • GENERAL ELECTRIC COMPANY
  • Sartorius AG
  • Merck KGaA, Darmstadt, Germany and/or its affiliates
  • Danaher
  • Fenner Group Holdings Limited

Global Downstream Processing Market Recent Developments

  • In Feb, 2024 ASF SE, headquartered in Ludwigshafen, Germany, officially announced the start of the divestiture process for its shares in two joint venture firms, BASF Markor Chemical Manufacturing (Xinjiang) Co, Ltd and Markor Meiou Chemical (Xinjiang) Co, Ltd, both based in Korla.
  • In January, 2024 MilliporeSigma has invested more than €300 million ($326 million) to build a bioprocessing production center in Daejeon, South Korea. The center will support and supply a variety of biotech products, including process liquids, dry powder cell culture medium, small-scale production, and sterile sampling devices.
  • In May, 2024 Greenwave Technology Solutions, Inc., an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, reported that their downstream processing system had achieved record revenue due to increased volume and higher prices.
  • In June, 2024, Sartorius has joined forces with Sanofi to co-develop and market an integrated continuous biomanufacturing (ICB) platform aimed at enhancing downstream efficiency. Sartorius will utilize its expertise in hardware, consumables, and process automation across all phases from development to commercialization.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market size of Global Downstream Processing Market in year 2024 is USD 3.26 billion.
The Global Downstream Processing Market CAGR is 11.3 % for the forecast period 2023-2031. The Global Downstream Processing Market size in 2023 is USD 2.94 billion and is projected reach USD 69.23 billion by 2031
Automation and Process Integration and Increasing Investment in Biopharmaceutical Manufacturing are driving the Global Downstream Processing Market growth.
Asia-Pacific is the fastest-growing region in the Global Downstream Processing Market. Growth is driven due to its expanding biopharmaceutical industry, increasing investments in advanced manufacturing technologies, and rising demand for biologics and biosimilar.
Our TRIPOD analysis involves comprehensive primary as well as secondary research to gather the data that is analyzed using credible data analysis methodologies involving Data Forecast Modelling, Porter’s Five Force Model, Demand Supply Chain Analysis, and Value Change Analysis.